TCM
EW icon

Tamarack Capital Management’s Edwards Lifesciences EW Stock Holding History

Tamarack Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-673,200
Closed -$7.81M – 33
2013
Q3 		$7.81M Buy
+673,200
New +$7.88M 2.07% 23

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tamarack Capital Management's EW Position: Q4 2013 in Review

Tamarack Capital Management sold out of Edwards Lifesciences (EW) in Q4 2013, closing a stake of 673,200 shares — an estimated $7.81M sold.

Tamarack Capital Management first reported a position in EW in Q3 2013 and held it in 1 quarter. The position peaked at $7.81M in Q3 2013. 407 funds tracked by Wall St. Rank hold EW as of Q4 2013.

  • Tamarack Capital Management reported no remaining Edwards Lifesciences position as of Q4 2013 after selling out during the quarter.
  • Tamarack Capital Management sold 673,200 Edwards Lifesciences shares in Q4 2013, an estimated $7.81M.
  • Tamarack Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 1 quarter.
  • Tamarack Capital Management's Edwards Lifesciences position peaked at $7.81M in Q3 2013.
  • 407 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on Tamarack Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.